A Canadian study is challenging the growing belief that previous infection with the Epstein-Barr virus (EBV) is necessary for multiple sclerosis (MS) to develop. The findings suggest the virus may not precede every MS case. Using public health insurance claims data, the researchers found a small group of…
Epstein-Barr virus (EBV)
A brain protein called anoctamin-2 (ANO2) has emerged as a new piece of the puzzle linking Epstein-Barr virus (EBV) infections to multiple sclerosis (MS), according to a study. Researchers found that immune T-cells from people with MS can mistake ANO2 for an EBV protein, triggering a cross-reactive response…
Recommended Posts
- Fenebrutinib again bests Aubagio in trial at cutting MS relapse rates
- I don’t have to be an Olympic medalist to achieve remarkable things
- New study links specific MRI lesion pattern to MS risk before symptoms
- With MS, parenting a teenager can get a little bloody — for dad
- Foralumab reduces microglial activity, inflammation in nonactive SPMS